Svoronos Dawn

Svoronos Dawn is listed in filings as Director at Xenon Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 3, 2026, including 19 public disclosures. Recent filings connect the profile to Xenon Pharmaceuticals Inc. (XENE), Adverum Biotechnologies, Inc. (ADVM), and Acelyrin, Inc. (SLRN). The current snapshot covers public activity from Jun 20, 2024 to Jun 3, 2026. Reported amounts are shown as $561.7K to $576.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.